Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

A comprehensive introduction and guide to High-Throughput Screening (HTS) by Cytometry, featuring assays, application data, and more. Chapters on popular and emerging applications, including new ...

Combined market-leading speed and 27 channel capacity enable maximum flexibility and data generation New fluidics and clog detection systems further simplify operation and reduce instrument downtime ...

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...

“For scientists driving the next breakthrough in antibody or cell therapy, speed is crucial, and no instrument can rival the speed of the iQue ® HTS Platform,” says Jonah Riddell, Product Manager of ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Artificial intelligence (AI) has been adopted in laboratories, not as a futuristic add-on but as a practical engine for accelerating experimentation and decision-making. Nowhere is this more evident ...

Southfield, Mich.-based Corewell Health and Secaucus, N.J.-based Quest Diagnostics have finalized a lab joint venture and hospital lab management agreement. Five things to know: 1. The new joint ...